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Objectives: Brucellosis remains one of the most common zoonotic diseases
worldwide. In humans, brucellosis can be a serious, debilitating, and sometimes
chronic disease. Different mechanisms can be postulated as to the basis for the
induction of the chronic status of infectious diseases that T regulatory cells are
one of the most important related mechanisms. The current study was designed
to determine whether percentage of CD4þTreg cells and their CD25high and
FoxP3high subpopulations in peripheral blood are changed in human brucellosis
samples in comparison to a control group.
Methods: In total, 68 brucellosis patients (acute form: n Z 43, chronic form:
nZ 25) and 36 healthy volunteers entered our study. After isolating of peripheral
blood mononuclear cells, heparinized venous blood samples were obtained from
both patients and healthy donors, CD4, CD25, and FoxP3 molecules were eval-
uated by two- and three-color flow cytometric methods.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
0) which permits unrestricted non-commercial use, distribution, and reproduction in any
roperly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
162 A. Bahador, et alResults: The results revealed a new finding in relation to Treg cells and human
brucellosis. The numbers of CD4þTreg cells and their CD25high and FoxP3high
subsets increase significantly in the peripheral blood of acute and chronic forms
of brucellosis samples compared with healthy groups, with this increase being
greater in the chronic group.
Conclusion: There seems to be a correlation between increase of CD4þTreg cells
and their subsets and the disease progress from healthy state to acute and
chronic brucellosis.1. Introduction
Brucellosis is an intracellular bacterial infection with
worldwide distribution with > 500,000 human cases
reported annually [1,2]. The disease is caused by or-
ganisms of the genus Brucella, especially by Brucella
melitensis, and is known as the most common zoonotic
disease [3]. In humans, the disease culminates in high
clinical morbidity and diverse clinical manifestations, as
any organ can be affected [4]. Despite early diagnosis
and treatment, approximately 10e30% of patients
develop chronic disease [5,6].
Host protection against intracellular pathogens such
as Brucella spp. depends on cell-mediated immunity
(CMI) [7,8]. Brucella can survive within macrophages
of the host and invades the normal mechanisms of
bacterial killing, causing chronic disease [6,7]. Th1
related cytokines [interleukin (IL)-12 and interferon-g],
which are fundamental for the clearance of brucellosis
agent, and percentages of ex vivo and phytohemagglu-
tinin (PHA)-cultured CD4þ T lymphocytes are found to
be diminished in chronic patients [9e11].
In recent years, regulatory T cells (Tregs) have
become a popular subject for immunological research.
Numerous reports shed light on the major aspects of
Treg biology in humans, with the characterization of
different T-cell subpopulations, including naturally
occurring CD4þ CD25þTregs, induced Tregs [IL-10
producing CD4þ type I regulatory T cells (Tr1) and T
helper type 3 (Th3) cells], and CD4þ CD25þ T cells
that develop in the periphery by conversion of CD4þ
CD25e T cells. All these different T-cell populations
with regulatory function coexist and contribute to im-
mune suppression [12e14].
There is now considerable evidence that CD4þCD25þ
Tregs represent a stable population of peripheral lympho-
cytes. These CD4þCD25þ Tregs represent about 5e10%
of human CD4þ T cells, and are commonly identified by
the constitutive expression of IL-2 receptor a (IL-2Ra;
CD25), as well as the transcription factor scurfin, encoded
by the forkhead family transcription factor 3 (Foxp3) gene
[15], and are also characterized by their very low levels of
proliferation on T-cell receptor (TCR) stimulation in vitro.
The CD4þ CD25high subset (which has high levels of
CD25 expression) in normal individuals comprises about1e3%of human circulatingCD4þT cells. Unlike the total
population of CD4þ CD25þ T cells, these CD4þ
CD25high cells constitutively expressing FoxP3 molecules
at high levels can significantly inhibit the proliferation and
cytokine secretion induced by TCR cross-linking of CD4þ
CD25 responder T cells, CD8þ T cells, dendritic cells,
natural killer cells, andBcells [16e20].However, FoxP3 is
emerged transiently in CD25low CD4þT lymphocytes,
which may be without suppressive activities; but they
contain effector functions [21].
The role of CD4þCD25hiT and CD4þFoxP3hiT cells
in immunopathology of Brucella infection has not yet
been elucidated [22]. So, in our study these cells were
evaluated to determine two substantial questions: is the
frequency of CD4þCD25highT, CD4þFoxP3highT,
CD4þCD25highFoxP3þ, and CD4þCD25þFoxP3high
cells increased in the peripheral blood (PB) of patients
with acute or chronic brucellosis as a direct result and, if
so, can these Treg cells impinge on antibacterial im-
mune responses as an inductive result, like other infec-
tious diseases.
2. Materials and methods
2.1. Participants
There were 104 unrelated participants enrolled in the
study: 68 brucellosis patients; and 36 healthy age- and
gender-matched volunteers who were used as controls.
According to disease history, clinical picture, and lab-
oratory findings, patients were divided into acute (AB)
and chronic (CB) brucellosis groups (Table 1).
The AB group included 43 consecutive patients. All
AB patients had a disease duration 8 weeks
(mean  standard deviation, 3.5  2.3 weeks). The
diagnosis was based on compatible clinical picture (Table
2) in combination to high serum titers of anti-brucellar
antibodies or fourfold increase of the initial titers in two
paired samples drawn 2weeks apart. In addition, in 19 out
of 43 AB patients, Brucella melitensis was isolated in
blood culture. In 33 patients brucellar DNA was detected
by PCR analysis in the blood and the serum.
The CB group was composed of 25 patients. All CB
patients had disease duration 6 months [23]. Thirteen
of 22 CB patients had also positive PCR analysis in
the blood.
Table 1. Demographic data of the groups (acute, chronic,
and control) studied
AB CB
Healthy
control
N 43 25 36
Female 14 8 13
Male 29 17 23
Age
(mean 
standard
deviation, y)
43.5  19.2 48.7  14.3 42.6  15.2
AB Z acute brucellosis; CB Z chronic brucellosis.
Increase of CD4þ T regulatory cells in Brucellosis 163High specific titers were defined by anti-brucellar
antibodies, which were considered for the Wright
agglutination test 1:320, for the Coombs’ agglutina-
tion test 1:320, and for the complement fixation test
32. Healthy volunteers were tested serologically for
brucellosis and found to be negative.2.2. Flow cytometry
Surface CD4 and CD25, and intracellular FoxP3
expression were assessed by flow cytometry using the
eBioscience human regulatory T cell staining kit Num-
ber 3 (eBioscience, San Diego, CA, USA). In brief, PB
mononuclear cells (PBMCs) were obtained by
FicolleHypaque density gradient centrifugation. Cells
were incubated with FITC anti-human CD4 (RPA-T4)
and PE anti-human CD25 (BC96) for 30 minutes at
4C.Then, after twice washing and fixing with fixation/
permeabilization solutions, the cells were stained with
PE-Cy5 anti-human FoxP3 (PH101), and incubated
similarly. Finally, two- and three-color fluorescence
flow cytometric analysis by a BD FACS Calibur
system were used to demonstrate the frequencyTable 2. Clinical characteristic of the patient groups
studied
AB
(n Z 43)
CB
(n Z 25)
Symptoms
Fever 43 6
Sweating 27 3
Chills 30 5
Malaise/fatigue 24 17
Arthalgias 19 10
Lumbar pain 16 6
Headache 13
Myalgias 11 10
Focal disease
Spondylitis 5 3
Sacroiliitis 3
Epididymoorchitis 3
Meningoencephalitis 6
AB Z acute brucellosis; CB Z chronic brucellosis.of CD4þCD25þ, CD4þ FoxP3þ and
CD4þCD25þFoxP3þ cells in PB samples.
2.3. Statistical analysis
Parametric statistical tests were applied as the vari-
ables were distributed normally (KolmogoroveSmirnov
test). Data were analyzed by one-way analysis of vari-
ance using SPSS version 21 (SPSS Inc., Chicago, IL,
USA) and were represented as mean  SD. A p value
<0$05 was considered to be statistically significant.
2.4. Ethics statement
Our study was confirmed by the ethical committee of
Tehran University of Medical Sciences, Tehran, Iran.
The participants were informed about the study and they
chose whether or not to participate in this study.3. Results
3.1. CD4DTreg cells and their subsets
The percentages of Treg cells were calculated as the
frequencies of CD4þCD25þ, CD4þCD25high,
CD4þFoxP3þ, CD4þFoxP3high, CD4þCD25þFoxP3þ,
CD4þCD25highFoxP3þ, and CD4þCD25þFoxP3high
cells in the CD4þ population of PBMCs, and their fre-
quencies were 6.7%, 2.0%, 1.5%, 0.4%, 1.4%, 0.41%, and
0.4% of CD4þ cells, respectively, in PBMCs of healthy
age-matched controls (Table 3, Figures 1 and 2). FoxP3þ
cells, similar to CD25þcells, were classified into two
subsets (FoxP3high and FoxP3low) based on the intensity of
FoxP3 expression (Figure 3).
The proportions of CD4þCD25þ cells included
16.6% in AB and 27.6% in CB patients. Also, the
CD25high subset of these cells contained 3.9% in AB and
6.8% in CB patients (Table 3, Figures 1 and 2).
CD4þFoxP3þ cells accounted for 5.7% of CD4þT-
cells in AB and 10.6% of CD4þT cells in CB patients.
In total CD4þlymphocytes, FoxP3high subpopulation
consisted of 1.6% and 2.9% in AB and CB, respectively.
In patients with AB, CD4þCD25þFoxP3þcells
comprised 5.06% of total CD4þ lymphocytes; in CB
patients, percentage of these cells was 9.5% of total
CD4þ lymphocytes (Table 3).
CD4þCD25highFoxP3þcells subtended 1.28% of
CD4þ lymphocytes in AB and 2.45% in CB patients.
Moreover, frequencies of CD4þCD25þFoxP3high cells
encompassed 1.41% and 2.03% of CD4þ lymphocytes
in attribution of AB and CB patients, respectively (Table
3, Figure 3).
3.2. Correlation between the level of CD25
expression in CD4D lymphocytes and
CD4DFoxP3Dcells
Correlation coefficients of CD4þCD25high cells and
CD4þFoxP3þ cells in the three groups consisted of
R Z 0.792, p < 0.001 (healthy control), R Z 0.817,
Table 3. Frequencies of Treg cell subsets determined by surface markers (CD4 and CD25) and intracellular FoxP3 levels
(p < 0.01)
Control Acute Chronic
Expression of surface markers (%)
CD4þCD25þ cells 6.7  1.8 16.6  4.2 27.6  6.4
CD4þCD25low cells 4.7  1.3 12.6  3.4 21.2  4.6
CD4þCD25high cells 2.0  0.5 3.9  1.1 6.8  2.1
Expression of intracellular Foxp3 molecule (%)
CD4þFoxp3þcells 1.5  0.6 5.7  1.8 10.6  2.5
CD4þFoxp3low cells 1.2  0.5 4.0  1.2 7.7  1.5
CD4þFoxp3high cells 0.4  0.2 1.6  0.4 2.9  0.60
CD4þCD25þFoxP3þcells 1.4  0.48 5.06  1.37 9.5  2.06
CD4þCD25lowFoxP3þcells 1.11  0.5 3.76  0.94 7.09  1.25
CD4þCD25highFoxP3þcells 0.41  0.18 1.28  0.47 2.45  0.57
CD4þCD25þFoxP3lowcells 1.18  0.48 3.57  1.11 5.28  1.32
CD4þCD25þFoxP3highcells 0.4  0.2 1.41  0.38 2.03  0.4
Data are presented as mean  SD.
164 A. Bahador, et alp < 0.001 (AB), and RZ 0.661, p < 0.001 (CB) versus
correlation between CD4þCD25low cells and
CD4þFoxP3þ cells with coefficients including
R Z 0.680, p < 0.001 (healthy control), R Z 0.586,
p < 0.001 (AB), and R Z 0.483, p Z 0.014 (CB;
Figure 4).Figure 1. Two-color flow cytometric analysis of CD4þCD25þ ce
cells and CD4þCD25low cell subsets. First, lymphocytes gated in F
then CD4þCD25- and CD4þCD25þ (high and low) gated in CD4. Discussion
Regulatory T cells (Treg cells) were originally
identified through their function in controlling autoim-
munity, where they mediate immunological tolerance to
self-antigens [24]. However, it later became apparentlls and subdivision of these cells tool into CD4þCD25high Treg
SC (forward light scatter)eSCC (side light scatter) dot plot and
4-FITC intensity versus CD25-PE intensity.
Figure 2. Percentages of (A) CD4þCD25high, (B) CD4þFoxP3high, (C) CD4þCD25highFoxP3þ, and (D) CD4þCD25þFoxP3high.
Treg cells within lymphocytes in the peripheral blood of healthy control (nZ 36), AB (nZ 43), and CB (nZ 25) groups. Difference
among groups was analyzed through the one-way analysis of variance test; and p values are shown on the figure;  represents extreme
values.
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antigens on pathogens [25]. The function of Treg cells
during infection appears to be primarily to prevent
collateral damage from unrestrained immune responses
to the pathogen, with a number of studies demonstrating
enhanced immunopathology with defective or depleted
Treg cells. It also seems that the induction of Treg cells
during infection is an immune subversion strategy
engaged by certain pathogens in order to last their sur-
vival in the host [26].
In agreement with other studies [11,27], we found
that the percentage expression of IL-2 receptor a on
peripheral CD4þlymphocytes in the healthy group was
<10% (data not shown). Also, in the current study, >
90% of FoxP3þ cells in all three groups were
CD4þFoxP3þ (data not shown), which implies that the
majority of FoxP3þTreg cells in healthy individuals,
AB, and CB patients manifest surface CD4 molecules.
In our study, the percentage of peripheral
CD4þCD25þ(low or high) T-lymphocytes was
increased in AB patients, as compared to controls,
suggesting that helper T-cells are activated in AB. This
finding adds further support to data presented by otherresearchers [11,28,29] and it approves that CD25 is
upregulated in AB patients. CB patients showed
significantly increased percentage of CD25 expression
on peripheral CD4þCD25high lymphocytes in compari-
son to AB patients. This seems to be in contrast with a
previous study by Skendros et al [11], which showed
diminished percentage in CD25 expression on periph-
eral CD4þT cells in compared with AB. But, they use
PHA in the culture of obtained PBMC for activating and
proliferating of lymphocytes and for this the acute
brucellosis group has the higher level of CD4þCD25low
cells as CD4þT-helper cells, were activated and
proliferated more than other groups. By contrast, the
increase of CD4þCD25high cells in PB of CB patients
and induced suppression of T cells by this Treg cells,
appears to be a substantial reason for the significant
reduction in the percentage of PHA-proliferating
TCD4þCD25þ cells and anergy induction in CB [30].
In addition, in our research, there were significant
increases in the proportions of CD4þFoxP3þcells and
their FoxP3high subpopulation, as well as
CD4þCD25þFoxP3þ cells and their CD25high or
FoxP3high subsets in CB in comparison to AB patients
Figure 3. Classification of CD4þFoxP3þ cells based on levels of intracellular FoxP3 expression (FoxP3high and FoxP3low) via
flow cytometric two-color method.
Figure 4. Correlation of CD4þFoxP3þ cells with CD4þCD25þ cells. CD4þCD25high cells exhibited more vigorous power of
coefficient to CD4þFoxP3þ cells than to CD4þCD25low T cells in all three groups (control, acute brucellosis, chronic brucellosis).
Each row was assigned to the one group, in which the left and the right diagrams depict the correlation among frequencies of
CD4þFoxP3þ cells with CD4þCD25low or CD4þCD25high cells, respectively.
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the AB group showed a significant increase in fre-
quencies compared with the control group.
According to Curiel et al [31], FoxP3 expression in
low levels can cause differentiation of Treg cells to Th2
or Th17 cells. So, the intensity of FoxP3 expression is
crucial in the state of Treg suppressive activity. In fact,
the presence of FoxP3 molecule maybe not only func-
tion as an on-and-off switch to offer suppressive activity
of Treg cells but also control the regulatory capacity of
these cells owing to the decreased function of Treg cells
due to attenuated FoxP3 expression [32]. Consequently,
our report about an increase of FoxP3þCD4þTreg
subsets in AB and CB patients versus control volunteers
indicates a significant rising trend in suppressive activ-
ities of the immune response in parallel with an ongoing
infection such as brucellosis.
By contrast, we found the relationship between
CD4þCD25high and CD4þFoxP3þ cells displayed a
stronger power of correlation coefficient than
CD4þCD25low and CD4þFoxP3þ cells in all three
groups. This positive correlation verifies the direct
relationship between the high-level intensity of CD25
(CD25high) and FoxP3 expression. Also, the AB group
(R Z 0.817) showed a better correlation of
CD4þCD25high and CD4þFoxP3þ cells compared with
the two other groups [R(healthy group) Z 0.792;
R(CB)Z 0.661], which may be due to the larger sample
size of the AB group (Figure 4).
In conclusion, our results demonstrate that there is a
marked increase in circulating CD4þ CD25þ,
CD4þFoxP3þ, and CD4þCD25þFoxP3þ Tregs and
their CD25high or FoxP3high subpopulations in AB and
CB patients. Tregs play a negative role not only in
modulating the effectors of immune responses by
inhibiting interferon-g secretion and cellular prolifera-
tion upon Brucella antigen stimulation, but also in
influencing the disease persistence in CB. These findings
suggest that modulation of CD4þ CD25þ Tregs might
be one potential therapeutic strategy for the treatment of
the chronic form of this infection. However, this study
was limited by analysis of the PB compartment only,
and further detailed investigation of the level and
function of CD4þ CD25þ and CD4þFoxP3þTregs in
brucellosis needs to be carried out.Conflicts of interest
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